American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Johnson Controls International
JCI
|
+$490M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Walmart
WMT
|
+$261M |
| 4 |
BHI
Baker Hughes
BHI
|
+$222M |
| 5 |
Wells Fargo
WFC
|
+$207M |
Top Sells
| 1 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$390M |
| 2 |
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
|
+$236M |
| 3 |
Air Products & Chemicals
APD
|
+$210M |
| 4 |
Applied Materials
AMAT
|
+$203M |
| 5 |
Cognizant
CTSH
|
+$178M |
Sector Composition
| 1 | Financials | 13.66% |
| 2 | Healthcare | 13.23% |
| 3 | Technology | 11.15% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Madison Square Garden
MSGS
$5.03B
| $2.44M | ﹤0.01% |
20,190
-3,857
| -16% | -$466K |
|
1027
National Fuel Gas
NFG
$7.95B
| $2.38M | ﹤0.01% |
+43,989
| New | +$2.38M |
|
|
PFPT
1028
DELISTED
Proofpoint, Inc.
PFPT
| $2.36M | ﹤0.01% |
31,570
-2,806
| -8% | -$210K |
|
1029
Central Garden & Pet
CENT
$2.28B
| $2.36M | ﹤0.01% |
+113,516
| New | +$2.36M |
|
|
MEET
1030
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $2.35M | ﹤0.01% |
+379,405
| New | +$2.35M |
|
1031
Enterprise Financial Services Corp
EFSC
$2.25B
| $2.34M | ﹤0.01% |
74,796
+42,882
| +134% | +$1.34M |
|
|
VAR
1032
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.33M | ﹤0.01% |
26,710
+131
| +0.5% | +$11.4K |
|
1033
Curtiss-Wright
CW
$19.3B
| $2.32M | ﹤0.01% |
25,491
| – | – |
|
1034
Sarepta Therapeutics
SRPT
$1.85B
| $2.31M | ﹤0.01% |
37,598
+3,442
| +10% | +$211K |
|
1035
United Therapeutics
UTHR
$18.2B
| $2.28M | ﹤0.01% |
19,269
-92,464
| -83% | -$10.9M |
|
1036
Exelixis
EXEL
$10.4B
| $2.27M | ﹤0.01% |
177,599
-189,323
| -52% | -$2.42M |
|
|
GCAP
1037
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $2.25M | ﹤0.01% |
364,443
+65,722
| +22% | +$406K |
|
1038
Northrop Grumman
NOC
$83.1B
| $2.24M | ﹤0.01% |
10,473
| – | – |
|
1039
Gannett
GCI
$626M
| $2.24M | ﹤0.01% |
+144,484
| New | +$2.24M |
|
1040
iShares MSCI Taiwan ETF
EWT
$6.5B
| $2.23M | ﹤0.01% |
71,035
+3,625
| +5% | +$114K |
|
1041
Travere Therapeutics
TVTX
$2.25B
| $2.2M | ﹤0.01% |
+98,096
| New | +$2.2M |
|
|
RDUS
1042
DELISTED
Radius Health, Inc.
RDUS
| $2.17M | ﹤0.01% |
40,195
-16,749
| -29% | -$906K |
|
1043
Koppers
KOP
$561M
| $2.16M | ﹤0.01% |
67,131
+4,148
| +7% | +$133K |
|
1044
V2X
VVX
$1.73B
| $2.16M | ﹤0.01% |
141,830
+94,180
| +198% | +$1.43M |
|
|
AMID
1045
DELISTED
American Midstream Partners, LP
AMID
| $2.14M | ﹤0.01% |
+144,810
| New | +$2.14M |
|
|
PGEM
1046
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $2.13M | ﹤0.01% |
159,523
+63,440
| +66% | +$847K |
|
|
RDUS
1047
DELISTED
Radius Recycling
RDUS
| $2.12M | ﹤0.01% |
101,646
+58,372
| +135% | +$1.22M |
|
1048
Pacira BioSciences
PCRX
$1.21B
| $2.1M | ﹤0.01% |
61,385
-5,006
| -8% | -$171K |
|
1049
Genesco
GCO
$360M
| $2.09M | ﹤0.01% |
+38,349
| New | +$2.09M |
|
1050
DHT Holdings
DHT
$1.96B
| $2.08M | ﹤0.01% |
497,135
+38,056
| +8% | +$159K |
|